Berikutnya

Putar otomatis

Differences in approaches to managing patients with multiple myeloma vs amyloidosis

11 Tampilan • 11/23/23
Membagikan
Menanamkan
administrator
administrator
Pelanggan
0

Beth Faiman, PhD, MSN, APRN-BC, AOCN, BMTCN, FAAN, Cleveland Clinic, Cleveland, OH, comments on the differences in management between patients with multiple myeloma and patients with amyloidosis, explaining that patients with amyloidosis experience different toxicities to anti-myeloma therapies and may require dose adjustments. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Menampilkan lebih banyak
0 Komentar sort Sortir dengan
Komentar Facebook

Berikutnya

Putar otomatis